Variant report

Variant	rs60392692
Chromosome Location	chr2:145349598-145349599
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 14 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:6)

rs_ID	r²[population]
rs57186573	0.85[AFR][1000 genomes]
rs57198048	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs72997874	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73008871	0.96[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73008880	0.81[AFR][1000 genomes]
rs73008887	0.81[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1067624	chr2:144657717-145425705	Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
2	nsv531413	chr2:144657717-145425705	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
3	nsv916172	chr2:144970681-145425713	Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
4	nsv948474	chr2:145035890-145436665	Enhancers Strong transcription Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
5	nsv1002563	chr2:145182201-145863253	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
6	nsv535957	chr2:145182201-145863253	Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
7	nsv531662	chr2:145219415-145422833	Flanking Active TSS Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
8	nsv529501	chr2:145257682-145485605	Active TSS Enhancers Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:25 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:145340000-145352000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr2:145341200-145352800	Weak transcription	Right Atrium	heart
3	chr2:145341800-145350200	Weak transcription	Primary B cells from peripheral blood	blood
4	chr2:145344400-145353200	Weak transcription	Primary hematopoietic stem cells	blood
5	chr2:145344600-145349800	Weak transcription	Primary monocytes fromperipheralblood	blood
6	chr2:145344600-145350000	Weak transcription	Monocytes-CD14+_RO01746	blood
7	chr2:145345200-145349800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr2:145345800-145350400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr2:145348400-145349800	Enhancers	HUES48 Cell Line	embryonic stem cell
10	chr2:145348600-145350200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr2:145348600-145350200	Enhancers	iPS-18 Cell Line	embryonic stem cell
12	chr2:145349200-145349600	Enhancers	iPS-20b Cell Line	embryonic stem cell
13	chr2:145349200-145349600	Enhancers	K562	blood
14	chr2:145349200-145350000	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr2:145349200-145350200	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr2:145349200-145350200	Enhancers	iPS-15b Cell Line	embryonic stem cell
17	chr2:145349200-145355000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
18	chr2:145349400-145349600	Enhancers	ES-I3 Cell Line	embryonic stem cell
19	chr2:145349400-145349600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr2:145349400-145349800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr2:145349400-145350000	Enhancers	Fetal Muscle Leg	muscle
22	chr2:145349400-145350200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr2:145349400-145350200	Enhancers	Brain Anterior Caudate	brain
24	chr2:145349400-145350400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr2:145349400-145350400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links